首页> 外文会议>IEEE International Conference on Bioinformatics and Bioengineering >Hacking the Immune Response to Infection in Chronic Obstructive Pulmonary Disease
【24h】

Hacking the Immune Response to Infection in Chronic Obstructive Pulmonary Disease

机译:黑攻击慢性阻塞性肺病中感染的免疫反应

获取原文

摘要

Efforts to treat chronic diseases are often obstructed by the complexity of the biological mechanisms supporting pathology. Here, we apply a novel method for discrete logical modeling of biological systems to the problem of infectious exacerbations in chronic obstructive pulmonary disease (COPD), using data from human clinical studies to constrain the selection of decisional logic parameters. We obtained two candidate models satisfactorily adhering to the available data. A predicted resting state with no activation of inflammatory markers was supported natively in one model, and could be induced following onset of an exacerbation episode in either model by applying targeted suppression of IL-4 concurrently with at least one additional inflammatory marker including IL-IB. Recapitulating a failed clinical trial of anakinra, suppression of IL-IB alone was not predicted to be sufficient. Instead, these results suggest that the efficacy of IL-IB suppression in the treatment of COPD might be improved by the added concurrent suppression of IL-4 and CCL4 or IL-4 and IL-17A.
机译:治疗慢性疾病的努力通常被支持病理学的生物机制的复杂性阻碍。在这里,我们应用一种新方法,用于生物系统的离散逻辑建模,以慢性阻塞性肺疾病(COPD)中的传染性恶化问题,使用人类临床研究的数据来限制抗议逻辑参数的选择。我们获得了两种候选模型,令人满意地遵守可用数据。在一种模型中本地支持没有激活炎性标记物的预测静止状态,并且通过将IL-4同时施用至少一种另外的炎症标记,可以在任一种模型中诱导在任一种模型中诱导发生的炎症发作的发作。包括IL-1B的另外的炎症标记。重新承载Anakinra的失败临床试验,单独抑制IL-IB的抑制是足够的。相反,这些结果表明IL-4和CCL4或IL-4和IL-17a的加同时抑制可以改善IL-IB抑制在COPD治疗中的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号